1
|
Nikam A, Sahoo PR, Musale S, Pagar RR, Paiva-Santos AC, Giram PS. A Systematic Overview of Eudragit ® Based Copolymer for Smart Healthcare. Pharmaceutics 2023; 15:pharmaceutics15020587. [PMID: 36839910 PMCID: PMC9962897 DOI: 10.3390/pharmaceutics15020587] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2023] [Revised: 02/02/2023] [Accepted: 02/07/2023] [Indexed: 02/12/2023] Open
Abstract
Eudragit, synthesized by radical polymerization, is used for enteric coating, precise temporal release, and targeting the entire gastrointestinal system. Evonik Healthcare Germany offers different grades of Eudragit. The ratio of methacrylic acid to its methacrylate-based monomers used in the polymerization reaction defines the final product's characteristics and consequently its potential range of applications. Since 1953, these polymers have been made to use in a wide range of healthcare applications around the world. In this review, we reviewed the "known of knowns and known of unknowns" about Eudragit, from molecule to material design, its characterization, and its applications in healthcare.
Collapse
Affiliation(s)
- Aniket Nikam
- Department of Pharmaceutical Chemistry, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, India
| | - Priya Ranjan Sahoo
- Department of Chemistry, University of Delhi, Delhi 110007, India
- Department of Chemistry, University at Buffalo, The State University of New York, Amherst, NY 14260, USA
| | - Shubham Musale
- Department of Pharmaceutics, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, India
| | - Roshani R. Pagar
- Department of Pharmaceutics, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, India
| | - Ana Cláudia Paiva-Santos
- Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, 3004-531 Coimbra, Portugal
- REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, 3004-531 Coimbra, Portugal
| | - Prabhanjan Shridhar Giram
- Department of Pharmaceutics, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, India
- Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY 14214, USA
- Correspondence:
| |
Collapse
|
2
|
Kulkarni D, Musale S, Panzade P, Paiva-Santos AC, Sonwane P, Madibone M, Choundhe P, Giram P, Cavalu S. Surface Functionalization of Nanofibers: The Multifaceted Approach for Advanced Biomedical Applications. Nanomaterials (Basel) 2022; 12:nano12213899. [PMID: 36364675 PMCID: PMC9655053 DOI: 10.3390/nano12213899] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Revised: 10/26/2022] [Accepted: 10/31/2022] [Indexed: 05/13/2023]
Abstract
Nanocarriers are gaining significant importance in the modern era of drug delivery. Nanofiber technology is one of the prime paradigms in nanotechnology for various biomedical and theranostic applications. Nanofibers obtained after successful electrospinning subjected to surface functionalized for drug delivery, biomedical, tissue engineering, biosensing, cell imaging and wound dressing application. Surface functionalization entirely changes physicochemical and biological properties of nanofibers. In physicochemical properties, wettability, melting point, glass transition temperature, and initial decomposition temperature significantly change offer several advantageous for nanofibers. Similarly, biological properties include cell adhesion, biocompatibility, and proliferation, also changes by functionalization of nanofibers. Various natural and synthetic materials polymers, metals, carbon materials, functional groups, proteins, and peptides, are currently used for surface modification of nanofibers. Various research studies across the globe demonstrated the usefulness of surface functionalized nanofibers in tissue engineering, wound healing, skin cancers, melanoma, and disease diagnosis. The delivery of drug through surface functionalized nanofibers results in improved permeation and bioavailability of drug which is important for better targeting of disease and therapeutic efficacy. This review provides a comprehensive insight about various techniques of surface functionalization of nanofibers along with its biomedical applications, toxicity assessment and global patent scenario.
Collapse
Affiliation(s)
- Deepak Kulkarni
- Department of Pharmaceutics, Srinath College of Pharmacy, Bajajnagar, Aurangabad 431136, India
| | - Shubham Musale
- Formulation and Development Department, Aculife Healthcare Pvt. Ltd., Sachana, Ahmedabad 382150, India
| | - Prabhakar Panzade
- Department of Pharmaceutics, Srinath College of Pharmacy, Bajajnagar, Aurangabad 431136, India
| | - Ana Cláudia Paiva-Santos
- Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, 3004-531 Coimbra, Portugal
- REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, 3004-531 Coimbra, Portugal
| | - Pratiksha Sonwane
- Department of Chemistry, Srinath College of Pharmacy, Bajajnagar, Aurangabad 431136, India
| | - Monika Madibone
- Department of Pharmaceutics, Srinath College of Pharmacy, Bajajnagar, Aurangabad 431136, India
| | - Puja Choundhe
- Department of Pharmaceutics, Srinath College of Pharmacy, Bajajnagar, Aurangabad 431136, India
| | - Prabhanjan Giram
- Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY 14214, USA
- Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pune 411018, India
- Correspondence: (P.G.); (S.C.)
| | - Simona Cavalu
- Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania
- Correspondence: (P.G.); (S.C.)
| |
Collapse
|
3
|
Kulkarni D, Damiri F, Rojekar S, Zehravi M, Ramproshad S, Dhoke D, Musale S, Mulani AA, Modak P, Paradhi R, Vitore J, Rahman MH, Berrada M, Giram PS, Cavalu S. Recent Advancements in Microneedle Technology for Multifaceted Biomedical Applications. Pharmaceutics 2022; 14:pharmaceutics14051097. [PMID: 35631683 PMCID: PMC9144002 DOI: 10.3390/pharmaceutics14051097] [Citation(s) in RCA: 28] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Revised: 05/07/2022] [Accepted: 05/17/2022] [Indexed: 02/04/2023] Open
Abstract
Microneedle (MNs) technology is a recent advancement in biomedical science across the globe. The current limitations of drug delivery, like poor absorption, low bioavailability, inadequate skin permeation, and poor biodistribution, can be overcome by MN-based drug delivery. Nanotechnology made significant changes in fabrication techniques for microneedles (MNs) and design shifted from conventional to novel, using various types of natural and synthetic materials and their combinations. Nowadays, MNs technology has gained popularity worldwide in biomedical research and drug delivery technology due to its multifaceted and broad-spectrum applications. This review broadly discusses MN’s types, fabrication methods, composition, characterization, applications, recent advancements, and global intellectual scenarios.
Collapse
Affiliation(s)
- Deepak Kulkarni
- Department of Pharmaceutics, Srinath College of Pharmacy, Bajajnagar, Aurangabad 431136, India;
| | - Fouad Damiri
- Laboratory of Biomolecules and Organic Synthesis (BIOSYNTHO), Department of Chemistry, Faculty of Sciences Ben M’Sick, University Hassan II of Casablanca, Casablanca 20000, Morocco; (F.D.); (M.B.)
| | - Satish Rojekar
- Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai 400019, India;
- Departments of Medicine and Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
| | - Mehrukh Zehravi
- Department of Clinical Pharmacy Girls Section, Prince Sattam Bin Abdul Aziz University, Alkharj 11942, Saudi Arabia;
| | - Sarker Ramproshad
- Department of Pharmacy, Ranada Prasad Shaha University, Narayanganj 1400, Bangladesh;
| | - Dipali Dhoke
- Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur 440033, India;
| | - Shubham Musale
- Department of Pharmaceutics, Dr. DY Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, India; (S.M.); (A.A.M.); (P.M.); (R.P.)
| | - Ashiya A. Mulani
- Department of Pharmaceutics, Dr. DY Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, India; (S.M.); (A.A.M.); (P.M.); (R.P.)
| | - Pranav Modak
- Department of Pharmaceutics, Dr. DY Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, India; (S.M.); (A.A.M.); (P.M.); (R.P.)
| | - Roshani Paradhi
- Department of Pharmaceutics, Dr. DY Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, India; (S.M.); (A.A.M.); (P.M.); (R.P.)
| | - Jyotsna Vitore
- National Institute of Pharmaceutical Education and Research, Ahmedabad 160062, India;
| | - Md. Habibur Rahman
- Department of Global Medical Science, Wonju College of Medicine, Yonsei University, Wonju 26426, Korea
- Correspondence: (M.H.R.); (P.S.G.); (S.C.)
| | - Mohammed Berrada
- Laboratory of Biomolecules and Organic Synthesis (BIOSYNTHO), Department of Chemistry, Faculty of Sciences Ben M’Sick, University Hassan II of Casablanca, Casablanca 20000, Morocco; (F.D.); (M.B.)
| | - Prabhanjan S. Giram
- Department of Pharmaceutics, Dr. DY Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, India; (S.M.); (A.A.M.); (P.M.); (R.P.)
- Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY 14260, USA
- Correspondence: (M.H.R.); (P.S.G.); (S.C.)
| | - Simona Cavalu
- Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 Decembrie 10, 410087 Oradea, Romania
- Correspondence: (M.H.R.); (P.S.G.); (S.C.)
| |
Collapse
|
4
|
Shinde DB, Pawar R, Vitore J, Kulkarni D, Musale S, Giram P. Natural and synthetic functional materials for broad spectrum applications in antimicrobials, antivirals and cosmetics. POLYM ADVAN TECHNOL 2021. [DOI: 10.1002/pat.5457] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Dasharath B. Shinde
- Symbiosis School of Biological Sciences (SSBS) Symbiosis International (Deemed University) Lavale Pune India
| | - Ranjitsinh Pawar
- Department of Pharmaceutics, Poona College of Pharmacy Bharati Vidyapeeth (Deemed to be University) Pune Maharashtra India
| | - Jyotsna Vitore
- Department of Pharmaceutics National Institute of Pharmaceutical Education and Research (NIPER) – Ahmedabad (An Institute of National Importance, Government of India) Gujarat India
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Gujarat, India
| | - Deepak Kulkarni
- Department of Pharmaceutics Srinath College of Pharmacy Aurangabad Maharashtra India
| | - Shubham Musale
- Department of Pharmaceutics Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research Pune India
| | - Prabhanjan Giram
- Department of Pharmaceutics Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research Pune India
| |
Collapse
|
5
|
Abstract
This review focuses on the process of preparation of nanofibers via Es, the design and setup of the instrument, critical parameter optimization, preferable polymers, solvents, characterization techniques, and recent development and biomedical applications of nanofibers.
Collapse
Affiliation(s)
- Atul Garkal
- Department of Pharmaceutics, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382481, India
| | - Deepak Kulkarni
- Department of Pharmaceutics, Srinath College of Pharmacy, Bajajnagar, Aurangabad, Maharashtra, 431136, India
| | - Shubham Musale
- Department of Pharmaceutics, Dr D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri-Pune, Maharashtra, 411018, India
| | - Tejal Mehta
- Department of Pharmaceutics, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, 382481, India
| | - Prabhanjan Giram
- Department of Pharmaceutics, Dr D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri-Pune, Maharashtra, 411018, India
| |
Collapse
|
6
|
Denny N, Musale S, Edlin H, Serracino-Inglott F, Thachil J. Chronic deep vein thrombosis. Acute Med 2018; 17:144-147. [PMID: 30129947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Deep vein thrombosis (DVT) is an important cause of short-term mortality and long-term morbidity. Although acute DVT is often well managed, there is uncertainty in the management of chronic DVT which is increasingly being noted among patients presenting with similar symptoms to their initial DVT. The presence of a residual venous clot can be a problem for both physicians and patients fearing the risk of emboli to the same extent as the acute DVT. There are also issues in the accurate diagnosis and appropriate management of chronic DVT, which is the focus of the second part of this review.
Collapse
Affiliation(s)
- N Denny
- Clinical fellow in Haematology, Department of Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| | - S Musale
- Medical Student, Department of Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| | - H Edlin
- Department of Vascular Surgery, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| | - F Serracino-Inglott
- Consultant Vascular Surgeon, Department of Vascular Surgery, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| | - J Thachil
- Consultant Haematologist, Department of Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| |
Collapse
|
7
|
Denny N, Musale S, Edlin H, Serracino-Inglott F, Thachil J. Iliofemoral deep vein thrombosis and the problem of post-thrombotic syndrome. Acute Med 2018; 17:99-103. [PMID: 29882562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Deep vein thrombosis (DVT) is an important cause of short-term mortality and long-term morbidity. Among the different presentations of DVT, thrombus in the iliofemoral veins may be considered the severest form. Although anticoagulation is the mainstay of the management of iliofemoral thrombosis, despite adequate anticoagulant treatment, complications including post-thrombotic syndrome is not uncommon. The latter is often overlooked but can cause considerable morbidity to the affected individuals. Preventing this condition remains a challenge but recent clinical trials of catheter directed thrombolysis and elasticated compression stockings provide some advance in this context. In this article, with the aid of a clinical case, we review the particular considerations to take into account when managing patients with an iliofemoral DVT.
Collapse
Affiliation(s)
- N Denny
- BMBCh, MRCP, Clinical fellow in Haematology, Department of Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| | - S Musale
- Medical Student, Department of Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| | - H Edlin
- Department of Vascular Surgery, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| | - F Serracino-Inglott
- MD, FRCSI, MSc, FRCS (Gen Surg), Consultant Vascular Surgeon, Department of Vascular Surgery, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| | - J Thachil
- MD, MRCP, FRCPath, Consultant Haematologist, Department of Haematology, Manchester Royal Infirmary, Manchester University NHS Foundation Trust
| |
Collapse
|